Navigating Renin-Angiotensin System Inhibitors in Patients with Declines in eGFR

1Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 2Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Correspondence: Dr. Jordana B. Cohen, email: [email protected] See related articles, "Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes," and "Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality," on pages XXX–XXX and XXX–XXX, respectively.